AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia: a report from the Children's Oncology Group.

Cooper, Todd M; Franklin, Janet; Gerbing, Robert B; Alonzo, Todd A; Hurwitz, Craig; Raimondi, Susana C; Hirsch, Betsy; Smith, Franklin O; Mathew, Prasad; Arceci, Robert J; Feusner, James; Iannone, Robert; Lavey, Robert S; Meshinchi, Soheil; Gamis, Alan.
Cancer; 118(3): 761-9, 2012 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-21766293